Low healthcare spending due to recession, not ACA, according to study

The majority of the recent decline in healthcare spending growth from 2009 to 2011 was due to the economic downturn, according to study published in the August issue of Health Affairs.

Approximately 70 percent of the decline was due to the economic downturn, not to factors such as health sector responses to the Affordable Care Act, according to the authors, who expect that as the economy recovers, health spending is likely to increase at a faster pace.

David Dranove, Craig Garthwaite, and Christopher Ody of the Kellogg School of Management at Northwestern University examined private insurance claims data covering 2007-2011 from the Health Care Cost Institute (HCCI) which represents the healthcare spending of nearly 47 million people with employer-sponsored insurance in all 50 states.

"The source of the slowdown in healthcare spending growth, and whether this slowdown will continue, has been much debated," said Dranove. "Our analysis shows that the slowdown was mostly due to the sluggish economy, not to structural change in the healthcare sector. The Affordable Care Act may ultimately succeed at reducing costs, but it hasn't done so yet."

From 2009-2011, health spending growth for this population slowed by 2.6 percentage points from the previous two years. By calculating the overall decline in employment during this period, the authors predict that health spending growth would have been 1.8 percentage points higher if the economy had not faltered in 2008. Thus, they concluded that 70 percent of the decline in healthcare spending growth was the result of the stagnant economy.

"There has been disagreement over the years as to whether health spending is recession proof. This study shows it's not," said Garthwaite.

The analysis, which focuses on privately-insured individuals, highlights that the slowdown in health spending was not solely caused by individuals who lost their jobs and employer-provided health insurance. "Even individuals who retained insurance during the downturn reigned in their health spending. This demonstrates the broad effects of a recession on health spending," said Garthwaite.

The researchers compared health spending in areas of the country affected by the economic downturn with areas that were largely unaffected. Insured people living in the hardest hit areas experienced the smallest increases in health spending.
 

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.